Sedative effects of low-dose risperidone in GAD patients and risk of drug interactions

J Clin Psychiatry. 2006 Aug;67(8):1307-8; author reply 1308-9. doi: 10.4088/jcp.v67n0821b.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / pharmacokinetics
  • Antipsychotic Agents / therapeutic use
  • Anxiety Disorders / drug therapy*
  • Disorders of Excessive Somnolence / chemically induced
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drug Interactions
  • Drug Therapy, Combination
  • Humans
  • Hypnotics and Sedatives*
  • Pilot Projects
  • Psychiatric Status Rating Scales
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Risperidone / adverse effects*
  • Risperidone / pharmacokinetics
  • Risperidone / therapeutic use
  • Sleep / drug effects
  • Treatment Outcome

Substances

  • Antipsychotic Agents
  • Hypnotics and Sedatives
  • Risperidone